본문 바로가기

Use of Bone Turnover Markers in Clinical Practice for the Management of Osteoporosis in Korea: From the Survey on the Prescription Pattern of Bone Turnover Markers

문서 유형
연구출판물 · 학술지 논문
등재
KCIScopus
저널
대한골대사학회지(JBM)26(4) · pp.271 · 2019
피인용
Scopus 3KCI 0
FWCI (Scopus)
0.28
ISSN
2287-6375

저자

  1. 안성희제1저자Division of Endocrinology and Metabolism, Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, 27 Inhang-ro, Jung-gu, Incheon, 22332, Korea
  2. 박소영Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyung Hee University Hospital, Seoul
  3. 유준일Department of Orthopaedic Surgery, Gyeongsang National University Hospital, Jinju
  4. 정윤지Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul
  5. 전윤경Division of Endocrinology and Metabolism, Department of Internal Medicine, Pusan National University Hospital, Busan
  6. 윤병호Department of Orthopaedic Surgery, Seoul Paik Hospital, Inje University College of Medicine, Seoul
  7. 김하영Division of Endocrinology, Department of Internal Medicine, Wonkwang University Sanbon Hospital, Wonkwang University School of Medicine, Gunpo
  8. 이승훈Division of Endocrinology and Metabolism, Asan Medical Center, University of Ulsan College of Medicine, Seoul
  9. 이제훈Department of Laboratory Medicine, College of Medicine, Catholic University of Korea, Seoul, Korea
  10. 홍성빈교신저자Division of Endocrinology and Metabolism, Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, 27 Inhang-ro, Jung-gu, Incheon, 22332, Korea

초록

Background: There has been interest in the clinical potential of bone turnover markers (BTMs) as tools both for assessing fracture risk and for monitoring treatment. However, the practical use of BTMs has been limited by their biological variability and difficulties in the interpretation of results. We investigated the current situation of application of BTMs by clinicians in Korea for the management of osteoporosis through a survey asking the patterns of BTMs prescription in clinical practice. Methods: The survey was conducted online using the “google survey” by the BTM committee authorized by the Korean Society for Bone and Mineral Research. Results: Total 108 clinicians responded the survey. Most of the respondents prescribed BTMs (80.6%) when they prescribed anti-osteoporotic medications (AOMs). The most frequently prescribed bone resorption and formation markers were serum C-terminal telopeptide of type I collagen (90.7%) and osteocalcin (65.1%), respectively. BTMs were mostly prescribed before starting AOMs (90.8%) and used for the purpose of evaluating treatment response (74.4%). Treatment response and compliance to AOMs were evaluated according to the change of absolute value of BTMs (55.1%). The respondents complained difficulties in the interpretation of BTMs (33.3%), the choice of proper BTMs (17.2%), and the proper sample preparation and handling (13.8%). Conclusions: In Korea, most of clinicians recognized the benefit of BTMs in the management of osteoporosis. However, there are limitations in the broad use of these markers in clinical practice. Therefore, a clear recommendation for BTM in Korea enhances their use in clinical practice.

키워드

BiomarkersBone remodelingOsteoporosis

식별자

Scopus EID
2-s2.0-85076290938
KCI
ART002529271